Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued in November 2022 addresses David M. Lubeck, M.D./Arbor Centers for EyeCare regarding drug products. Without access to the full letter text or detailed subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the issuing office details are not specified in the metadata provided.